Corpus Intelligence IC Memo — NORTHWEST MEDICAL CENTER 2026-04-26 09:34 UTC
IC Memo — NORTHWEST MEDICAL CENTER
Investment Committee Memorandum | FL | 289 beds | Grade C | EBITDA uplift $19.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

NORTHWEST MEDICAL CENTER

CCN 100189 | nan, FL | 289 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

NORTHWEST MEDICAL CENTER is a 289-bed suburban community hospital in nan, FL with $262.8M in net patient revenue and a 18.8% operating margin. The hospital serves a payer mix of 13.7% Medicare, 4.7% Medicaid, and 81.5% commercial.

Thesis: Platform Growth. Our ML models identify $19.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 18.8% to 26.1% (+736bps).

Net Revenue HCRIS$262.8M
Current EBITDA COMPUTED$49.3M
Operating Margin COMPUTED18.8%
Occupancy HCRIS61.6%
Revenue / Bed COMPUTED$909K
Net-to-Gross HCRIS9.4%
Distress Probability ML43.8%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
105
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 18.8% places it above the state median. Among 105 size-comparable peers (144-578 beds), the median margin is 3.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (144-578), prioritizing same-state peers. 105 hospitals in the comp set.

HospitalStateBedsRevenueMargin
NORTHWEST MEDICAL CENTER (Target)FL289$262.8M18.8%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
ASCENSION SACRED HEART PENSACOFL559$1.04B-10.0%
MOUNT SINAI MEDICAL CENTER OF FL481$904.2M12.2%
TALLAHASSEE MEMORIAL HOSPITALFL483$871.6M-4.8%
SHANDS JACKSONVILLE MEDICAL CEFL481$861.4M-7.1%
MORTON PLANT HOSPITALFL561$773.1M7.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $19.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.5M+210bp18mo
Cost to Collect4.5%2.5%$5.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.2M+122bp9mo
Clean Claim Rate88.0%96.0%$168K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.5M
Cost to Collect
$5.3M
Denial Rate Reduction
$5.2M
A/R Days Reduction
$3.2M
Clean Claim Rate
$168K
Total EBITDA Uplift$19.3M
Current EBITDA$49.3M
+ RCM Uplift+$19.3M
Pro Forma EBITDA$68.7M
Current Margin18.8%
Pro Forma Margin26.1%
WC Released (1x)$10.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$75.9M$518.9M6.84x46.9%
Base (11x exit)10.0x11.0x$75.9M$595.5M7.84x51.0%
Bull Case9.0x11.0x$68.3M$684.0M10.01x58.5%
Bull (12x exit)9.0x12.0x$68.3M$766.3M11.22x62.2%
Bear Case11.0x10.0x$83.5M$397.5M4.76x36.6%
Bear (11x exit)11.0x11.0x$83.5M$464.4M5.56x40.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 105 hospitals with 144-578 beds
  • Same-state prioritization (n=106)
  • Comp margins: P25=-5.1% / P50=3.2% / P75=16.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.